Share
Facebook Facebook icon Twitter Twitter icon LinkedIn LinkedIn icon Email

Diversity, Equity, and Inclusion

Harnessing the power of the outsider perspective 

Published 24 October 2024 in Diversity, Equity, and Inclusion • 7 min read

Jean-Louis Barsoux, Cyril Bouquet, and Michael Wade extract key leadership lessons from the story of Dr Patricia Bath, the inventor of modern cataract surgery and the first African-American woman to receive a medical patent – despite huge odds.  

Innovation is widely viewed as an engine of progress; not only for driving economic growth and bringing vital improvements in fields such as science and medicine, but also for tackling issues like social inequality.

Given that anyone can have a good idea, you might expect the distribution of US patents to reflect the demographics of the workplace. Sadly, as we know, this is far from the case. Multiple studies show that two groups lag far behind: women and African Americans.

Their underrepresentation in the fields of science, technology, engineering, and math (STEM subjects) is often used as an explanation for this imbalance. But data also shows that STEM-trained women and African Americans are far less likely to apply for patents than White males. This points to the existence of significant barriers blocking underrepresented groups from realizing their breakthrough ideas – yet it is these “outsiders” who can bring the kind of combinatorial thinking crucial for novel solutions. With fewer preconceptions than insiders, they can more easily connect disparate thoughts.

In 1986, Bath filed a patent for a laser technique to treat cataracts

Key skills of outsiders

The story of Dr Patricia Bath, a groundbreaking ophthalmologist and the inventor of modern cataract surgery, is a powerful example of how those considered outsiders possess key skills for developing innovative solutions — and the formidable barriers they face when attempting to introduce their much-needed innovations to society.

In 1986, Bath filed a patent for a laser technique to treat cataracts. Two years later, aged 45, she became the first African American woman to receive a medical patent. Her invention was a breakthrough in combating preventable blindness that has helped improve or restore the sight of millions of people worldwide.

But Bath’s journey was a tortuous one. In 1969, as a young Black woman in a White male preserve, she faced gender, racial, and age biases that affected her perceived credibility and, therefore, ability to advance in her chosen field. But she used one of the key advantages conferred by her demographic differences and fresh perspective: the ability to see problems that others missed. Pursuing a medical internship at Harlem Hospital and a fellowship in ophthalmology at Columbia University, she quickly noticed a glaring disparity: the prevalence of blindness among African Americans was double that of White Americans. And, by trawling through the medical records of patients at both clinics, she realized that this was no genetic quirk but rather the result of poor access to proper eye care (foreshadowing revelations of health inequity in marginalized communities during the Covid-19 pandemic).

Bath persuaded her professors at Columbia to operate for free on blind patients in Harlem, where she got a crash course in cornea and cataract surgery as a volunteer assistant surgeon. Four years later, when she became the first woman faculty member at UCLA’s Jules Stein Eye Institute, she was forced to prove herself all over again, and only after refusing to work in an office in the basement next to the lab animals was she able to secure a more suitable location to work.

Research shows that these forms of indirect, subtle, and often unintentional discrimination also inhibit cognitive performance.

Cumulative effect of microaggressions

For many women and minorities, the cumulative effect of such microaggressions impacts their self-esteem and organizational commitment. Research shows that these forms of indirect, subtle, and often unintentional discrimination also inhibit cognitive performance. As such, they are bound to erode engagement in innovation, which demands focus, self-belief, and a willingness to challenge orthodoxy. At UCLA Bath pursued her interest in health disparities and enlisted the help of two African Americans from outside her discipline to set up the American Institute for the Prevention of Blindness, which champions sight as a basic human right. The nonprofit initiated a new approach – combining aspects of public health, community medicine, and clinical ophthalmology – now known as community ophthalmology, that changed the course of medicine and is now practiced worldwide.

While not belonging to the demographic majority may bestow a creative edge in terms of spotting issues and generating alternative solutions, not being part of the in-group makes it much harder to marshal the resources and backing needed to push ideas through the system. Unsurprisingly, many people give up.

Bath confronted this barrier when she conceived the radical idea of dissolving cataracts using lasers — a technology primarily associated with defense systems and blinding laser weapons at the time. She believed her approach could be less invasive and faster than existing treatments. Unfortunately, the ecosystem at UCLA did not support her work and her colleagues offered zero encouragement. “When I talked to people about it,” she recalled, “They said it couldn’t be done.” Bath conducted initial experiments in her lab, but UCLA did not have the necessary lasers, and she was unable to secure grants to pursue her research in the US. Instead of giving up, as many would have done, she reached out to connections abroad and “nagged them until they agreed to provide access to their labs.”

Eventually, she was able to finalize her complex three-in-one device – a tiny probe consisting of an optical laser fiber surrounded by irrigation and suction tubes – at UCLA and performed her first tests on donor eyes. Having perfected the technique, she reported her scientific breakthrough to the lab director. His response spoke volumes: “You didn’t do that,” he told her. “That’s impossible.” He wouldn’t look her in the face.

Bath is notable not only for her inventions and advances in medical practice but also for her incredible persistence and determination to overcome the barriers that could have derailed her at multiple points in her innovation journey.

Negative impact of low expectations on performance

Such disbelief betrayed low expectations on the part of Bath’s lab director. Decades of research have established the negative impact of low expectations on performance. Known as the Golem effect, this also extends to innovation. Fortunately, by this stage in her career, Bath was robust enough not to be deterred by negativity and kept her “eyes focused on the prize,” but for aspiring innovators, such slights or expressions of skepticism can be as damaging to their motivation as overt discrimination, crushing people’s confidence and resolve.

Bath went on to improve the laserphaco probe, as she called it, and the method for using it several times, resulting in five US patents (the last of which was awarded in 2003 for a combination laser and ultrasound cataract device) and her technique remains in use worldwide.

Bath died in May 2019. In one of her last public appearances, she testified before the US Senate Judiciary Subcommittee on the hidden obstacles facing women inventors and depriving the US of more innovation, saying, “Based on my own personal experience, the oversights, slights, and disrespect of scientific contributions of women scientists and inventors demonstrated in the 1960s continues even today.”

Among the 610 inductees in the US National Inventors Hall of Fame, there are only 48 women and just 30 African Americans. Until 2022, there was still not one Black woman inductee, with Bath becoming the first (after being nominated 11 years running), along with engineer Marian Croak. (Bath was also posthumously inducted into the National Women’s Hall of Fame in March 2024.)

Bath is notable not only for her inventions and advances in medical practice but also for her incredible persistence and determination to overcome the barriers that could have derailed her at multiple points in her innovation journey. It makes you wonder: How many important innovations is the US still missing out on because of biases and systems that make it extraordinarily difficult for those on the margins to bring their breakthrough ideas to life?

There are lessons in this story for us all. Outsiders like Patricia Bath are able to see the world with fresh eyes and can come up with ideas and solutions that challenge conventional thinking. We need to pay closer attention to these perspectives, which means acknowledging the biases, low expectations, and skepticism that often get in the way.

This is a shortened version of an article that first appeared in MIT Sloan Management Review on 8 February 2022.

All views expressed herein are those of the author and have been specifically developed and published in accordance with the principles of academic freedom. As such, such views are not necessarily held or endorsed by TONOMUS or its affiliates.

Authors

Jean-Louis Barsoux

Research Professor at IMD

Jean-Louis Barsoux helps organizations, teams, and individuals change and reinvent themselves. He was educated in France and the UK, and holds a PhD in comparative management from Loughborough University in England. His doctorate provided the foundation for the book French Management: Elitism in Action (with Peter Lawrence) and a Harvard Business Review article entitled The Making of French Managers.

Cyril Bouquet - IMD Professor

Cyril Bouquet

Professor of Innovation and Strategy at IMD

Cyril Bouquet is Director of the Innovation in Action program, co-Director of the TransformTECH program and  the Business Creativity and Innovation Sprint. As an IMD professor, his research has gained significant recognition in the field. He helps organizations reinvent themselves by letting their top executives explore the future they want to create together.

Michael Wade - IMD Professor

Michael R. Wade

TONOMUS Professor of Strategy and Digital

Michael R Wade is TONOMUS Professor of Strategy and Digital at IMD and Director of the TONOMUS Global Center for Digital and AI Transformation. He directs a number of open programs such as Leading Digital and AI Transformation, Digital Transformation for Boards, Leading Digital Execution, Digital Transformation Sprint, Digital Transformation in Practice, Business Creativity and Innovation Sprint. He has written 10 books, hundreds of articles, and hosted popular management podcasts including Mike & Amit Talk Tech. In 2021, he was inducted into the Swiss Digital Shapers Hall of Fame.

Related

Learn Brain Circuits

Join us for daily exercises focusing on issues from team building to developing an actionable sustainability plan to personal development. Go on - they only take five minutes.
 
Read more 

Explore Leadership

What makes a great leader? Do you need charisma? How do you inspire your team? Our experts offer actionable insights through first-person narratives, behind-the-scenes interviews and The Help Desk.
 
Read more

Join Membership

Log in here to join in the conversation with the I by IMD community. Your subscription grants you access to the quarterly magazine plus daily articles, videos, podcasts and learning exercises.
 
Sign up
X

Log in or register to enjoy the full experience

Explore first person business intelligence from top minds curated for a global executive audience